Isotope-Labeled Excipient Market Revenue, Insights, Overview, Outlook, Analysis

Isotope-Labeled Excipient Market

Isotopic labeling is a technique which identifies drug products and detects counterfeits. Over the globe, pharmaceutical companies face a major problem of drug counterfeit, and the adoption of isotope-labeled excipients helps in reducing such products which are either manufactured with no active pharmaceutical ingredients (API), wrong API, or an incorrect amount of API. Counterfeiting issues are a major concern in the pharmaceutical market owing to poor regulatory scenario, a high number of intermediaries, and lack of awareness among end users.

The global Isotope-Labeled Excipient market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-5P8380/Global_Isotope_Labeled_Excipient_Market_Insights_Forecast_to_2028

North American market for Isotope-Labeled Excipient is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Isotope-Labeled Excipient is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Isotope-Labeled Excipient include Molecular Isotope Technologies, Cambridge Isotope Laboratories, CIL Isotope Separations, Membrane Receptor Technologies, Marshall Isotopes, CortecNet and Medical Isotopes, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Isotope-Labeled Excipient, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Isotope-Labeled Excipient.

Report Scope

The Isotope-Labeled Excipient market size, estimations, and forecasts are provided in terms of output/shipments (Kiloton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Isotope-Labeled Excipient market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Isotope-Labeled Excipient manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Type
• Deuterium
• Carbon-13
• Oxygen-18
• Nitrogen-15
• Other Stable Isotopes

By Application
• Agriculture
• Biomolecular NMR
• Metabolic And Nutrition
• Research

Key Companies
Molecular Isotope Technologies, Cambridge Isotope Laboratories, CIL Isotope Separations, Membrane Receptor Technologies, Marshall Isotopes, CortecNet, Medical Isotopes

View Full Report: https://reports.valuates.com/market-reports/QYRE-Auto-5P8380/global-isotope-labeled-excipient

Please reach us at sales@valuates.com

Address:
Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.